IP Library Granted Patent US 7,662,750
Granted Patent B2
US 7,662,750 · App. 11/005,194 · Granted Feb 16, 2010

Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds

Assignees: The Research Foundation of State University of New York; Roswell Park Cancer Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,662,750
App. No.
11/005,194
Granted
Feb 16, 2010
Kind
B2
Abstract

The present invention relates to 1,4-disubstituted naphthalene scaffold compounds and other closely related scaffold compounds. The present invention also relates to combinatorial libraries of such compounds. In addition, the present invention relates to a method of identifying a protein-protein interaction antagonist. The method first involves providing a compound as described herein. Next, the compound is contacted with interacting proteins of a protein-protein interaction target complex, whereby the compound is allowed to compete with the interacting proteins. Then, the activity of the compound for inhibiting formation of the protein-protein interaction target complex is measured. Finally, the compound that inhibits formation of the protein-protein interaction target complex is identified as a protein-protein interaction antagonist. Also disclosed is a method for modulating a protein-protein interaction. The method involves contacting interacting proteins of a protein-protein interaction target with a compound as described herein, whereby the protein-protein interaction between the interacting proteins is modulated.

Claims (52)

1. A compound having the following formula:

wherein:

R 1 -R 2 are individually selected from the group consisting of: H, C 1 -C 12 alkyl, heteroatom and multiple heteroatom substituted C 1 -C 12 alkyl, C 1 -C 12 branched or cyclic alkyl, aryl and substituted aryl, heteroaryl and substituted heteroaryl, substituted alkylaryl, amines, CH 2 COOCH 2 CH 3 , CH 2 COOH, and CH 2 C≡C, wherein the substitution in any of the substituted groups comprises substituents selected from the group consisting of hydrogen, halogen, oxygen, OH, OCH 3 , and methyl;

R 3 is H; and

R 4 is 3-fluorophenyl.

2. The compound according to claim 1 , wherein the compound has the following structure:

3. The compound according to claim 1 , wherein the compound has the following structure:

4. The compound according to claim 1 , wherein the compound has the following structure:

5. The compound according to claim 1 , wherein the compound has the following structure:

6. The compound according to claim 1 , wherein the compound has the following structure:

7. The compound according to claim 1 , wherein the compound has the following structure:

8. The compound according to claim 1 , wherein the compound has the following structure:

9. The compound according to claim 1 , wherein the compound has the following structure:

10. The compound according to claim 1 , wherein the compound has the following structure:

11. The compound according to claim 1 , wherein the compound has the following structure:

12. The compound according to claim 1 , wherein the compound has the following structure:

13. The compound according to claim 1 , wherein the compound has the following structure:

14. The compound according to claim 1 , wherein the compound has the following structure:

15. The compound according to claim 1 , wherein the compound has the following structure:

16. The compound according to claim 1 , wherein the compound has the following structure:

17. The compound according to claim 1 , wherein the compound has the following structure:

18. The compound according to claim 1 , wherein the compound has the following structure:

19. The compound according to claim 1 , wherein the compound has the following structure:

20. The compound according to claim 1 , wherein the compound has the following structure:

21. The compound according to claim 1 , wherein the compound has the following structure:

22. The compound according to claim 1 , wherein the compound has the following structure:

23. The compound according to claim 1 , wherein the compound has the following structure:

24. The compound according to claim 1 , wherein the compound has the following structure:

25. The compound according to claim 1 , wherein the compound has the following structure:

26. The compound according to claim 1 , wherein the compound has the following structure:

27. The compound according to claim 1 , wherein the compound has the following structure:

28. The compound according to claim 1 , wherein the compound has the following structure:

29. The compound according to claim 1 , wherein the compound has the following structure:

30. The compound according to claim 1 , wherein the compound has the following structure:

31. The compound according to claim 1 , wherein the compound has the following structure:

32. The compound according to claim 1 , wherein the compound has the following structure:

33. The compound according to claim 1 , wherein the compound has the following structure:

34. The compound according to claim 1 , wherein the compound has the following structure:

35. The compound according to claim 1 , wherein the compound has the following structure:

36. The compound according to claim 1 , wherein the compound has the following structure:

37. The compound according to claim 1 , wherein the compound has the following structure:

38. The compound according to claim 1 , wherein the compound has the following structure:

39. A compound having the following formula:

wherein:

R 1 is selected from the group consisting of H, C 1 -C 12 alkyl, substituted C 1 -C 12 alkyl, C 3 -C 12 branched or cyclic alkyl, aryl and substituted aryl, heteroaryl and substituted heteroaryl, substituted alkylaryl, amines, CH 2 COOCH 2 CH 3 , CH 2 COOH, and CH 2 C≡C, wherein the substitution in any of the substituted groups comprises substituents selected from the group consisting of hydrogen, halogen, oxygen, OH, OCH 3 , and methyl;

R 2 is H or methyl;

R 3 is H; and

R 4 is 3-fluorophenyl.

40. The compound according to claim 39 , wherein R 2 is H.

41. The compound according to claim 39 , wherein R 1 is selected from the group consisting of H, C 1 -C 4 alkyl, substituted C 1 -C 4 alkyl, C 3 -C 4 branched or cyclic alkyl, aryl and substituted aryl, heteroaryl and substituted heteroaryl, and CH 2 C≡C, wherein the substitution in any of the substituted groups comprises substituents selected from the group consisting of hydrogen, halogen, OH, and OCH 3 .

42. The compound according to claim 39 , wherein R 1 is selected from the group consisting of H, C 1 -C 4 alkyl, C 3 -C 4 branched or cyclic alkyl, phenyl, benzyl, thiazole, thiadiazole, triazole, isoxazole, amines, CH 2 COOCH 2 CH 3 , CH 2 COOH, and CH 2 C≡C, wherein C 1 -C 4 alkyl, phenyl, benzyl, thiazole, thiadiazole, triazole, and isoxazole are optionally substituted with substituents selected from the group consisting of hydrogen, halogen, methyl, OH, and OCH 3 .

43. The compound according to claim 42 , wherein R 1 is selected from the group consisting of H, C 1 -C 4 alkyl, C 3 -C 4 branched or cyclic alkyl, phenyl, benzyl, thiazole, thiadiazole, triazole, isoxazole, and CH 2 C≡C, wherein C 1 -C 4 alkyl, phenyl, benzyl, thiazole, thiadiazole, triazole, and isoxazole are optionally substituted with substituents selected from the group consisting of hydrogen, halogen, methyl, OH, and OCH 3 .

Assignments (5)
CONFIRMATORY LICENSE Recorded Dec 28, 2023
From: RESEARCH FOUNDATION OF STATE UNIVERSITY OF NY, UNIVERSITY AT BUFFALO
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 065969/0250 →
CONFIRMATORY LICENSE Recorded Jul 31, 2017
From: STATE UNIVERSITY OF NEW YORK AT BUFFALO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043140/0131 →
CONFIRMATORY LICENSE Recorded Oct 27, 2008
From: STATE UNIVERSITY OF NEW YORK AT BUFFALO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021743/0636 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2005
From: LEE, MADISON; PRUITT, STEVEN
To: ROSWELL PARK CANCER INSTITUTE
Reel/Frame 016315/0674 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2005
From: HANGAUER, DAVID G.; JI, TAO
To: RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE
Reel/Frame 016318/0564 →
Continuity (2)
Provisional Application 6052710200 · Dec 4, 2003
Related Publication 20050153366A1 · Jul 14, 2005